A research team at the Max Planck Institute for Chemical Ecology has successfully combined single-cell RNA sequencing ...
Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...
On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...
The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.
Illumina’s up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation ...
The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an ...
Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...
"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...
Illumina was hit with a patent infringement lawsuit on Sept. 22 in Delaware District Court over its DNA sequencing systems and associated kits. The action, brought by Quinn Emanuel Urquhart & Sulliva ...
Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback